< 1 minute read
Jan. 17, 2022
RP-3500 is an Oral ATR Kinase Inhibitor
RP-3500
ATR kinase inhibitor phase I/IIa candidate for advanced solid tumors from lipid-kinase inhibitor scaffold Molecular Cancer Therapeutics Repare Therapeutics, Saint-Laurent, CAN
Loading...
